NCT02203825 Safety Study of Chimeric Antigen Receptor Modified T-cells Targeting NKG2D-Ligands Status COMPLETED Phase PHASE1
NCT02176031 Phase II Trial of Natalizumab + Prednisone for Initial Therapy of Acute GI GVHD Status COMPLETED Phase PHASE2
NCT02172651 Vitamin D in Patients With Stage I-III Colon Cancer or Resectable Colon Cancer Liver Metastases Status RECRUITING Phase EARLY_PHASE1
NCT02171078 Post-Treatment Surveillance in Breast Cancer: Bringing CER to the Alliance Status COMPLETED Phase N/A
NCT02164240 Phase Ib Study of SUnitinib Alternating With REgorafenib in Patients With Metastatic and/or Unresectable GIST Status COMPLETED Phase PHASE1
NCT02158091 A Phase 1b/2 Study of IPI-145 Plus FCR in Previously Untreated, Younger Patients With CLL Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT02137252 Naltrexone RCT for Treatment-Emergent Fatigue in Patients Receiving Radiation Therapy for Breast Cancer Status TERMINATED Phase PHASE2
NCT02135133 A Study of Idelalisib (GS1101, CAL101) + Ofatumumab in Previously Untreated CLL/SLL Status COMPLETED Phase PHASE2
NCT02133625 A Study of Pioglitazone and Carboplatin in Patients With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT02129686 A Pilot Study of Acupuncture for Chemotherapy-induced Peripheral Neuropathy in Breast Cancer Patients Status COMPLETED Phase NA
NCT02123966 An Open Label Phase II Trial of Topical Sirolimus for the Treatment of Refractory Oral Chronic Graft-versus-Host-Disease Status TERMINATED Phase PHASE2
NCT02119897 Feasibility Study of Low Level Light Therapy for Prevention of Oropharyngeal Mucositis in Pediatric Transplants Patients Status COMPLETED Phase NA
NCT02118987 Study of Omalizumab as Adjuvant Therapy in Chemotherapy Desensitization Status COMPLETED Phase PHASE1
NCT02117336 Clinical Study of Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL) Status SUSPENDED Phase PHASE1
NCT02113878 Phase Ib Study of BKM120 With Cisplatin and XRT in High Risk Locally Advanced Squamous Cell Cancer of Head and Neck Status COMPLETED Phase PHASE1
NCT02091245 Phase I Trial of the Selective Inhibitor of Nuclear Export, KPT-330, in Relapsed Childhood ALL and AML Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT02091232 Infusion of T-Regulatory Cells in Kidney Transplant Recipients (The ONE Study) Status COMPLETED Phase PHASE1